When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. Roche settles US patent lawsuit against Biogen over ... - AOL

   www.aol.com/news/roche-settles-us-patent-lawsuit...

   By Blake Brittain (Reuters) - Swiss pharmaceutical company Roche has settled a patent lawsuit against U.S. biotech firm Biogen over its biosimilar version of Roche's blockbuster rheumatoid ...

3. Why Roche Stock Just Popped, but Eli Lilly and Novo Nordisk ...

   www.aol.com/why-roche-stock-just-popped...

   But good news for Roche is bad news for the companies that now seem to have the weight-loss drug market to themselves. Shares of Eli Lilly (NYSE: LLY) were down 2.8% today, and Novo Nordisk (NYSE ...

4. Roche shares knocked by concern over side effects in ... - AOL

   www.aol.com/news/roche-shares-drop-side-effects...

   FRANKFURT (Reuters) -Shares in Roche dropped to a two-month low on Thursday after an experimental weight-loss pill that carries high market hopes was linked to an elevated rate of temporary side ...

5. Roche Products, Inc. v. Bolar Pharmaceutical Co. - Wikipedia

   en.wikipedia.org/wiki/Roche_Products,_Inc._v...

   Roche was a brand-name pharmaceutical company which made and sold a sleep aid Dalmane, the active ingredient of which Flurazepam was protected by patent. [ 1 ] Before patent expiration, Bolar used the patented chemical in experiments to determine if its generic product was bioequivalent to Dalmane in order to obtain FDA approval for its generic ...

6. Pharma Stock Roundup: Roche to Buy ONCE, Lawmakers ... - AOL

   www.aol.com/news/pharma-stock-roundup-roche-buy...

   Roche (RHHBY) to buy Spark Therapeutics for $4.8 billion. Executives of big pharma companies face senators' questions over high drug prices.

7. Look Out, Eli Lilly and Novo Nordisk: Could Roche Be the ...

   www.aol.com/finance/look-eli-lilly-novo-nordisk...

   Roche might give Lilly and Novo Nordisk a run for their money -- sometime down the road.

8. Roche faces further delay in $4.3 bln Spark deal amid ... - AOL

   www.aol.com/news/roche-again-extends-4-3...

   Roche on Friday announced another extension of its $4.3 billion offer for gene therapy specialist Spark Therapeutics, this time until June 3, saying a review by U.S. authorities is taking longer ...

9. Weight Loss Drug Stocks Just Took a Hit. Should You Buy the ...

   www.aol.com/finance/weight-loss-drug-stocks-just...

   For premium support please call: 800-290-4726 more ways to reach us